Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational Study to Assess Real-World Outcomes in Patients With Unresectable Liver Tumors Initiating Treatment With SIR-Spheres (Y-90 Resin Microspheres) (SIRtain Registry)

NCT05967143 is registered in ClinicalTrials.gov with Sirtex Medical as lead sponsor.

NCT NCT05967143
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05967143 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational Study to Assess Real-World Outcomes in Patients With Unresectable Liver Tumors Initiating Treatment With SIR-Spheres (Y-90 Resin Microspheres) (SIRtain Registry)
Lead sponsor
Sirtex Medical
Phase
Observational
Overall status
Recruiting
Start date
June 19, 2023
Completion date
June 30, 2029
Enrollment
845 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

liver metastases from colorectal cancer (mcrc), unresectable hepatocellular carcinoma (hcc)